ArticleFrontiers in immunology2025
Identification of key genes related to metabolic cell death in hepatic ischemia-reperfusion injury from transcriptome data and mechanism research using single-cell data.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ferroptosis and cuproptosis are closely associated with hepatic ischemia-reperfusion injury (HIRI). However, the significance of metabolic cell death-related genes (MRGs) in HIRI still awaits exploration. This study examined the molecular mechanisms through which key genes contribute to metabolic cell death in HIRI. Methods: GSE12720, GSE14951, and GSE171539 datasets and 478 MRGs were included. First, candidate genes were screened through differential expression analysis combined with MRGs. Then, key genes were identified by using machine learning algorithms combined with expression verification. Subsequently, the analyses included constructing and evaluating nomograms, conducting functional enrichment studies, characterizing immune infiltration, building regulatory networks, performing drug prediction, and executing molecular docking. Importantly, single-cell analysis was conducted to identify key cell populations Finally, expression levels of key genes in animal samples were determined by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results: The analysis identified ATF3, TNFAIP3, IL1B, and KDM6B as central genes. The nomogram indicated that these four key genes could well predict the occurrence of HIRI. Functional enrichment analysis revealed significant associations of ATF3, TNFAIP3, and KDM6B with olfactory transduction pathways. The key genes were positively linked to most differential immune cells, and ATF3 had the most significant positive relation to activated CD4 T cells. The binding energies of molecular docking between key genes and corresponding drugs were all less than -5 kcal/mol. Mononuclear phagocytes were identified as key cells, and the expressions of ATF3, IL1B, and KDM6B had dynamic and non-linear change characteristics during the differentiation of mononuclear phagocytes. RT-qPCR results demonstrated that ATF3, TNFAIP3, IL1B, and KDM6B were up-regulated in HIRI samples, consistent with the results in the GSE12720 and GSE14951 datasets. Conclusion: In HIRI pathogenesis research, ATF3, TNFAIP3, IL1B and KDM6B were validated as core regulators of metabolic cell death, offering critical targets for mechanistic investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.